Active Studies

To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC

This study is a 4-week, multicenter, randomized, double-blind, placebo-controlled, ascending
dose, 4-period crossover study designed to evaluate the safety, tolerability, efficacy, and
PK of JZP-110 (75, 150, and 300 mg) in the treatment of excessive sleepiness in adult
subjects with idiopathic PD.

A study of a drug to be used in addition with another drug to treat adults with Uncontrolled
Partial-onset Seizures

The purpose of this study is to compare two different exercise programs to see if there are
differences after exercise in fibromyalgia (FM) symptoms and responses from the immune

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics (PK)
of 5 escalating doses of SRP-5051 administered as a single dose to patients with DMD amenable
to exon 51 skipping treatment.